Shire Hits Sandoz With 2nd Suit Over Generic Intuniv
Shire filed the lawsuit after Sandoz, the generic-pharmaceuticals division of Novartis AG, amended its application to make the generic version to include 1-milligram, 2-milligram and 3-milligram dosages. Sandoz's original application was for a 4-milligram dose.
Dublin-based Shire claims Sandoz's generic version, in any dosage, would violate three Intuniv patents.
Shire says it...
To view the full article, register now.